Intraperitoneal prolactin administration to female rats caused a isoenzymes suggesting that prolactin affects these isoforms. rapid and transient stimulation of hepatic mitogen-activated Concomitant with the increase in MAP kinase activity, prolactin kinase (MAP kinase) activity measured in vitro as cytosolic induced tyrosine phosphorylation in a number of liver proteins, phosphotransferase capacity towards two specific substrates.
INTRODUCTION
In addition to the classic effects on mammary gland [1] the pituitary peptide hormone prolactin is involved in a broad spectrum ofphysiological processes, including differentiation and proliferation, in a variety of tissues [2, 3] . Prolactin effects are initiated by interaction with a specific receptor, which belongs to a large family of transmembrane proteins, including the receptors for growth hormone, erythropoietin, interleukin 2, 3, 4 and 6 and granulocyte-macrophage colony-stimulating factor [4] [5] [6] . A high concentration of prolactin receptors has been demonstrated in rat liver [5] . Acute administration of prolactin to rats elevates hepatic DNA synthesis, and chronic treatment causes hepatic hypertrophy [7] . The intracellular domain of the prolactin receptor does not possess any consensus sequence for intrinsic tyrosine kinase activity and ATP binding [5] . Although activation of protein kinase C (PKC) seems to play a role in the hepatic effects of prolactin [7] , the actual signal-transduction pathway remains largely unknown.
In the present work we have investigated whether prolactin treatment stimulates mitogen-activated protein (MAP) kinase, a key component of the signalling pathway responsive to a wide range of mitogens and extracellular stimuli in different cell types [8, 9] . Possible relationships between MAP kinase and other kinases were also studied. Animals and treatment Female Wistar rats weighing 200 g from Nossan (Correzzana, Italy) were used. They were maintained with alternating 12 h cycles of light and dark and fed on a balanced diet ad libitum. Ovine prolactin was administered intraperitoneally at a dose of 22 mg/kg body weight [10] , which causes an increase in hepatic DNA synthesis [11] . The animals were killed by decapitation (performed at 13:00 h) 5, 10, 20 and 30 min after prolactin injection, and the livers were rapidly excised.
MATERIALS AND METHODS

MAP kinase activity
Livers were homogenized with 20 mM Tris/HC1, pH 7.4, containing 150 mM NaCl, 2 mM EGTA, 80 mM ,i-glycerophosphate, 1 mM phenylmethanesulphonyl fluoride, 1 mM sodium orthovanadate, 0.1 mM sodium molybdate, 0.1 % Triton X-100, 2 mM dithiothreitol, 20 ,ug/ml leupeptin and 0.1 mg/ml aprotinin. The samples were mixed briefly, kept on ice for 10 min and centrifuged at 100000 g for 60 min. Supernatants were assayed for MAP kinase activity as described by Campbell et al. [12] using two different substrates: MBP (10,ug) and MAP kinase substrate peptide [13, 14] (25 ug) .
Cytosolic proteins (15,ug) Liver cytosolic proteins (300 ,ug) in 500 ,l of buffer containing 25 mM Tris/HCl (pH 8), 0.5 mM EGTA (pH 7.4), 137 mM NaCl, 1 % Nonidet P-40, 1 mM sodium orthovanadate, 10 mM NaF and protease inhibitors were immunoprecipitated with 4 ,ug of anti-(MAP kinase R2) antibody or preimmune rabbit serum for mock precipitation. The mixture was rocked for 4 h at 4 The beads were spun and two 20 ,l portions of supernatant were spotted on P-8 1 phosphocellulose paper, washed and counted for radioactivity as described above. Radioactivity in the preimmune serum immunoprecipitate was subtracted from that in the MAP kinase immunoprecipitate [15] . Portions of supernatant were also analysed by SDS/PAGE. Gels were dried and exposed to Kodak X-Omat film for autoradiography.
Preparation of lysates from rat liver
Rat livers were dissolved (1:10, w/v) in boiling SDS lysis buffer [63 mM Tris/HCl, pH 6.8, containing 2% (w/v) SDS, 25 % (v/v) glycerol, 100 mM sodium orthovanadate, 0.1 mM sodium molybdate, 100 Jg/ml leupeptin and 100 Jetg/ml aprotinin] [12] , boiled for 5 min, mixed vigorously, frozen and stored at -80 'C before electrophoresis. Protein was determined by the Bradford method [16] . lmmunoblot analysis Lysate or cytosolic protein (80-150 Jag) was subjected to SDS/PAGE in 10% polyacrylamide gels [17] and transferred to PVDF membranes using a Bio-Rad Trans-Blot semi-dry cell [18] . The membranes were blocked with 3 % BSA in 10 mM Tris/HCl pH 7.4, containing 150 mM NaCl (Tris-buffered saline) then probed with either monoclonal anti-phosphotyrosine HRPconjugated antibody, diluted to 1 Jug/ml in Tris-buffered saline containing 3 % BSA, for 3 h or polyclonal anti-(rat MAP kinase R2) antibody, diluted to 0.5 ,ug/ml in Tris-buffered saline containing 0.1 % BSA and 0.1 % Tween-20, for 2 h. Anti-(MAP kinase) antibody was detected using biotinylated anti-species secondary antibody, streptavidin-biotinylated HRP complex. When the same blots were used for both determinations, the blots were stripped by incubation in stripping buffer (100 mM 2-mercaptoethanol, 2 % SDS, 62.5 mM Tris/HCl, pH 6.7) for 1 h at 50 'C. After this procedure the blots were blocked with buffer containing 3 % BSA and reprobed with a different antibody [19] . Immunoreactive proteins were made visible by the ECL method.
Densitomaetric analysis was performed with an LKB Ultroscan laser deinsitometer.
Assay of PKC activity Extracts of rat liver membranes were prepared as previously described [20] . The fractions were partially purified using DEAEcellulose (DE-52) [21] , and PKC activity was determined by an in vitro phosphorylation assay using histone HI (type III) as substrate in the presence or absence of 500,uM CaCl2 in excess of chelator concentration, 1 ug of diolein and 25,ug of phosphatidylserine. PKC assays were carried out at 30°C for 10 min.
PKC activity was calculated by subtracting the basal activity from the values of kinase activity in the presence of CaCl2 and phospholipids; data are expressed as pmol of 32P transferred/ 10 min per mg of protein.
Statistical analysis
Significance of differences was tested by Student's t test.
RESULTS
The effects of prolactin administration were assessed by comparison with normal controls as rats injected with vehicle at various times of treatment were always in the normal range.
The involvement of MAP kinase activity in the signal-transmission mechanism of PRL in rat liver was studied by means of various procedures.
In vitro MAP kinase activity
The first series of experiments was designed to evaluate the phosphotransferase activity of crude cytosolic liver extracts towards MBP which is an excellent substrate for MAP kinases in vitro [8] . The activity was readily detectable in control animals and showed a significant increase (+ 66 %) as early as 5 min after prolactin treatment (Table 1) . Maximum activation occurred at 10 min ( + 100 %), a slight decline in enzyme activity was observed at 20 min (+ 83 %) and then the values returned to the normal range after 30 min.
The second series of experiments was performed with a more specific substrate for MAP kinase, a synthetic nonapeptide containing the threonine-phosphorylation site for the enzyme [13, 14] . Under these experimental conditions, MAP kinase ac- Immunoblotting experiments Multiple MAP kinase isoforms exist. They require phosphorylation in both tyrosine and threonine residues for maximal activation [8, 22] . To identify the isoenzymes involved in prolactininduced MAP kinase activation we examined the electrophoretic behaviour of MAP kinase proteins and their phosphotyrosine content by immunoblotting experiments. When cytosolic liver proteins from control rats were probed with the polyclonal anti-(MAP kinase) antibody, which recognizes the products of erkl-erk2 and mpk genes, three bands were detected (Figure 2a ): an abundant 43 kDa protein and two minor proteins of 44 and 40 kDa. In prolactin-treated rats a small fraction of the 40 kDa MAP kinase showed a lower electrophoretic mobility with respect to control animals which presumably reflects the increase in its phosphorylation, as observed also by others [23, 24] . This slight shift occurred as soon as 5 min after treatment and was maintained for 20 min thereafter. The same blots, after removal ofanti-(MAP kinase) antibodies, or the other half of Western blots from identical samples, were then probed with an anti-phosphotyrosine monoclonal antibody. The phosphotyrosine signal was clearly detected in the upper region of the 40 kDa protein where the prolactin-induced shift occurs and in the correspondence of the 44 kDa band (Figure 2b) .
Kinase assays performed on renatured proteins in gels polymerized in the presence of MBP as substrate as described by Kameshita and Fujisawa [25] provided no better information than previous immunoblotting experiments. In crude cytosolic liver extracts from both control rats and those treated for 5 and 10 min with prolactin, 32P was mostly incorporated into the 43-44 kDa region. Densitometric analysis demonstrates that this incorporation increases by 20 % as early as 5 min after hormonal injection. In the 40 kDa region the amount of 32P was smaller and it never displayed the upwards shift (results not shown). tivity showed different absolute values but the extent of the prolactin effect was very similar and its time course was superimposable on that of the former experiments (Table 1) .
MBP phosphorylation assay by MAP kinase immunoprecipitates
To confirm the above results, the cytosolic liver proteins were subjected to immunoprecipitation with polyclonal anti-(MAP kinase R2) antibody followed by assay of kinase activity toward MBP. The immunoprecipitates from control animals were able to phosphorylate MBP and prolactin treatment stimulated this kinase activity (Figure la) . By this procedure the extent of the prolactin effect was always greater than that seen when the kinase was assayed in crude extracts. The increase in 32P in MBP PKC has been implicated in the transmembrane signalling of the prolactin-induced stimulus to cell proliferation [26] and there is evidence for a PKC-dependent mechanism in the regulation of MAP kinase activity [27, 28] ; therefore we evaluated the time course of liver PKC activity after prolactin treatment. Investigations of in vitro PKC activity soon (5-10 min) after treatment revealed no changes, and a 10 % non-significant increase was evident only 20 min after prolactin injection (4855 + 64 pmol of 32P incorporated into histone/ 10 min per mg ofprotein compared with a control value of 4363+355pmol/lOmin per mg of protein). These observations exclude the involvement of PKC as a trigger of prolactin-induced MAP kinase activity, which occurs as early as 5 min after hormonal treatment.
Tyrosine kinase activity in cytosol and membrane preparations assayed by in vitro phosphorylation of the synthetic substrate poly(GluNaTyr) (4:1) [29] was the same in control and prolactintreated rats (results not shown).
Analysis of tyrosine phosphorylation in liver proteins from control and prolactin-treated rats by anti-phosphotyrosine immunoblotting of whole cell lysates (Figure 3) confirmed the increase in phosphotyrosine in the 40 Our results are consistent with the hepatic mitogenic action of prolactin [30] and with the key role of MAP kinases in cell-cycle activation [8, 9] : MAP kinase is responsible for the earliest events that occur in the release of cells from cell-cycle arrest, such as activation of transcriptional factors and downstream kinases [31] .
It has been recently reported that growth hormone and granulocyte-macrophage colony-stimulating factor stimulate MAP kinase activity in 3T3 F442A fibroblasts and human neutrophils respectively [12, 19] . The analogies between the receptors for these two agents and that of prolactin [4] can explain the similarity between these results and our own.
PKC appears to be involved in mediating prolactin action in several target tissues [23, 32] including rat liver [10, 30, 33] , and has been implicated in regulation of the MAP kinase cascade [27, 28] . However, the fact that the membrane-bound PKC activity begins to increase only 20 min after prolactin injection seems to exclude a role for this enzyme in MAP kinase activation, which is seen as soon as 5 min after hormone treatment. Also the ability of growth hormone to stimulate MAP kinase in 3T3-F442A cells does not depend on PKC activation [34] .
We have shown that prolactin induces a prompt increase in tyrosine phosphorylation of 115 and 94 kDa rat liver proteins concomitant with MAP kinase activation. Evidence for rapid tyrosine kinase activation has been reported in prolactin-treated Nb2 lymphoma cells in vitro [35] : prolactin promotes tyrosine phosphorylation of proteins of similar size in Nb2 cells [36] and rat liver cells. Quite recently the association of prolactin receptor with p607Yc [37] and the involvement of the Janus tyrosine kinase family in signal transduction ofprolactin [38] have been reported. Thus, as demonstrated for growth-hormone and interleukin 2 receptors [39] , a mechanism involving the association of prolactin receptor with other cellular proteins endowed with tyrosine kinase activity seems probable; the rapid tyrosine phosphorylation of a number of cellular proteins is in keeping with this possibility.
The pathways that regulate MAP kinase activity include a kinase cascade which might be activated by different mechanisms [22, 40] , and very recently a possible relationship between Janus kinase 2 and MAP kinase was proposed in a model for cytokine signalling pathways [41] . Additional investigations are needed to clarify whether and how prolactin-induced tyrosine kinase activity is relevant to MAP kinase activation in the liver. Studies are in progress to identify the upstream factors responsible for prolactin-induced MAP kinase activation.
